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OBJECTIVE — To examine the association between white blood cell (WBC) count and met-
abolic syndrome (MetS) by growth periods in black versus white individuals in the general
population.
RESEARCH DESIGN AND METHODS — The study cohort consisted of 4,184 black
and white preadolescents, adolescents, and adults. In this cohort, 743 adults were followed for
8.1–20.8 years longitudinally.
RESULTS — White versus black subjects had a signiﬁcantly higher WBC count in all age-
groups. WBC count was associated with more MetS components in whites than in blacks. Mean
valuesofWBCincreasedsigniﬁcantlywithincreasingnumberofMetScomponentswithadverse
levels in adolescents and adults, with a stronger trend in whites. WBC count was longitudinally
associated with MetS in whites only (P  0.001).
CONCLUSIONS — The ﬁndings on the association between higher WBC count and MetS
beginning in childhood, particularly in whites, underscore a potentially mechanistic link be-
tween systemic inﬂammation, MetS, and cardiovascular risk.
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E
pidemiological and clinical studies
have shown that white blood cell
(WBC) count, an important cellu-
lar marker of systemic inﬂammation, is
associated with coronary heart disease,
type 2 diabetes, and multiple compo-
nents of metabolic syndrome (MetS),
including obesity, insulin resistance,
hypertension, and dyslipidemia (1–4).
The objective of the present study is
to examine the association between
WBC count and MetS by age-group,
cross-sectionally and longitudinally, in
black versus white asymptomatic indi-




surveys of children aged 4–17 years in
1988–1993 and two surveys of young
adults aged 18–38 years in 1988–1996
were conducted for cardiovascular risk
factors, including WBC count. Individu-
als who had a WBC count outside the
clinically normal range (below 2,000
cells/lorabove12,000cells/l)wereex-
cluded from analyses to remove inﬂuence
of acute bacterial infection and other
medical disorders. Subjects who were
taking medications for hypertension, dia-
betes,and/ordyslipidemiaorhadmissing
values for any of the MetS risk variables
were also excluded. The ﬁnal sample size
for the current cross-sectional analysis was
1,137 preadolescents (aged 4–11 years),
1,542 adolescents (aged 12–17 years), and
1,503adults(aged18–38years).Inthisco-
hort,asubsetof743adultswasfollowedfor
8.1–20.8 years with a mean follow-up pe-
riod of 12.7 years.
Statistical methods
BMI(inchildren),waistcircumference(in
adults), HDL cholesterol, fasting triglyc-
erides, and fasting glucose were selected
as MetS components. In cross-sectional
analysis of preadolescents, adolescents,
and adults, the sex- and age-speciﬁc top
quartiles (bottom quartile for HDL cho-
lesterol) were used to deﬁne the adverse
levels of the MetS components by race
groupbecausewidelyacceptedcutoffval-
ues are not available for preadolescents
and adolescents. In the longitudinal adult
cohort, the National Cholesterol Educa-
tion Program (NCEP) Adult Treatment
Panel III (ATPIII) cutoffs were used to de-
ﬁne the adverse levels. Pearson correla-
tion was used to assess the association of
WBC count with the MetS components,
adjusting for age, sex, and smoking (for
adults). The difference in the correlation
coefﬁcients between race groups was
tested by Fisher z test.
RESULTS— White versus black sub-
jects had a signiﬁcantly higher WBC
count among preadolescents (6,472 vs.
5,927 cells/l, P  0.001), adolescents
(6,270vs.5,697cells/l,P0.001),and
adults (6,496 vs. 6,037 cells/l, P 
0.001). The racial differences in preva-
lence of MetS were signiﬁcant in preado-
lescents (whites versus blacks: 18.5 vs.
12.9%, P  0.05) and in adults (14.5 vs.
19.2%, P  0.05), but not in adolescents
(15.2 vs. 14.3%, P  0.05). Mean values
of WBC increased signiﬁcantly with the
increasing number of MetS components
with adverse levels in adolescents (P 
0.001inwhites,P0.040inblacks)and
adults (P  0.001 in whites, P  0.015 in
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tion coefﬁcients of WBC count with MetS
risk variables by race and age-groups, ad-
justing for age sex and smoking (for
adults), in cross-sectional and longitudi-
nal analyses. In general, WBC was associ-
ated with more MetS variables in whites
thaninblacks,especiallyamongadults,in
both cross-sectional and longitudinal
analyses. Furthermore, in the longitudi-
nal analyses, the mean values of baseline
WBC count increased signiﬁcantly with
the increasing number of MetS compo-
nents with adverse levels at follow-up in
whites(P0.001),butnotinblacks(P
0.137).
CONCLUSIONS — The present study
demonstrated a pronounced black-white
difference in the relationship between
WBC count and MetS risk variables in
children and young adults in both cross-
sectional and longitudinal analyses. The
Coronary Artery Risk Development in
Young Adults (CARDIA) study investi-
gated correlates of leukocyte count in
4,981 black and white young adults aged
18–30yearssimilartotheagerangeofthe
present study cohort; however, the data
were not analyzed separately by race
group (5). In the Atherosclerosis Risk in
Communities (ARIC) study, the associa-
tions of WBC count with sociodemo-
graphic and cardiovascular risk factors
were examined in 4,832 white and 1,830
blacknonsmokersaged45–64years;this
cross-sectional analysis did not show
black-white difference in the associa-
tions for most of the risk factors (6).
Therefore, the ﬁndings of the black-
white contrasts in the present study
need conﬁrmation, particularly in pop-
ulations of similar ages.
In the present study, WBC count was
signiﬁcantly lower in blacks than in
whites; this racial difference persisted
from childhood into adulthood. This ob-
servation is consistent with reports from
other studies (5–7). However, levels of C-
reactive protein, another biomarker of
inﬂammation, were found to be signiﬁ-
cantly higher in blacks than in whites in
our previous report in a cohort from the
same community (8). Although blacks
have higher prevalence rates of type 2 di-
abetes and cardiovascular disease (9),
studies, including ours, in both children
and adults showed lower prevalence of
MetS in blacks (10–12). It is proposed
that the ethnic differences in triglycerides
and HDL cholesterol levels lead to under-
diagnosis of MetS in blacks (12). In the
cross-sectional analysis of the present
study, the prevalence of MetS was found
to be lower in black preadolescents but
higher in black adults than their white
counterparts. Taken together, the patho-
physiologicalmechanismsunderlyingthe
association between WBC count and




Whites Blacks Whites Blacks Whites Blacks
n 712 425 902 642 1,082 421
Age (years) 4–11 4–11 12–17 12–17 18–38 18–38
BMI 0.104** 0.017 0.159*** 0.115** 0.219*** 0.133**
Waist circumference 0.214*** 0.112*
Systolic BP 0.095* 0.107* 0.082* 0.018 0.144*** 0.032†
Diastolic BP 0.022 0.048 0.065 0.017 0.136*** 0.028‡
Glucose 0.081* 0.085 0.051 0.139*** 0.012 0.002
Log-insulin 0.072 0.042 0.105** 0.030‡ 0.237*** 0.097†
Log-HOMA-IR 0.051 0.018 0.052 0.041 0.192*** 0.083
HDL cholesterol 0.088* 0.084 0.109** 0.032 0.076* 0.032
Log-triglycerides 0.115** 0.149** 0.179*** 0.140*** 0.305*** 0.122*†
Heart rate 0.156*** 0.082 0.141*** 0.152*** 0.104** 0.127**
Uric acid 0.046 0.033 0.096** 0.071 0.148*** 0.062
Longitudinal analysis
Baseline Follow-up
Whites Blacks Whites Blacks
n 538 205 538 205
BMI 0.180*** 0.039 0.221*** 0.086
Waist circumference 0.197*** 0.005† 0.224*** 0.028†
Systolic BP 0.139** 0.055 0.134** 0.190**
Diastolic BP 0.134** 0.016 0.121** 0.241***
HDL cholesterol 0.075 0.050 0.129** 0.009
Log-triglycerides 0.163*** 0.092 0.171*** 0.071
Heart rate 0.111** 0.061 0.097* 0.090
Uric acid 0.134** 0.034 0.119** 0.007
Different from zero: *P  0.05; **P  0.01; ***P  0.001. Racial difference: †P  0.05; ‡P  0.01. BP, blood pressure; HOMA-IR, homeostasis model assessment
of insulin resistance.
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